An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring

Rachel A. Egler, Yiting Li, Tu Anh T. Dang, Tricia L. Peters, Eastwood Leung, Shixia Huang, Heidi V. Russell, Hao Liu, Tsz Kwong Man

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Purpose: Despite intensive treatment regimens, overall survival for high-risk neuroblastoma (HRNB) is still poor. This is in part due to an inability to cure the disease once a patient has reached clinical relapse. Identifying plasma biomarkers of active disease may provide a way of relapse monitoring in HRNB. Experimental design: In this study, we developed an integrated proteomic approach to identify plasma biomarkers for HRNB. Results: We identified seven candidate biomarkers (SAA, APOA1, IL-6, EGF, MDC, sCD40L and Eotaxin) for HRNB. These biomarkers were then used to create a multivariate classifier of HRNB, which showed a specificity of 90% (95% confidence interval (CI), 73%, 98%), and a sensitivity of 81% (95%CI, 54%, 96%) for classifying HRNB in a training set. When evaluated on independent test samples, the classifier exhibited 86% accuracy (95% CI, 42%, 100%) of identifying diagnostic samples, and 86% accuracy (95% CI, 70%, 100%) of detecting post-diagnosis longitudinal samples that having active disease. Conclusion and clinical relevance: Further validation of these biomarkers may improve patients' outcomes by developing a simple blood test for the detection of relapse prior to the development of clinically evident disease. Understanding the role of these biomarkers in immune surveillance of neuroblastoma may also provide a new direction of therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)532-541
Number of pages10
JournalProteomics - Clinical Applications
Volume5
Issue number9-10
DOIs
StatePublished - Oct 2011
Externally publishedYes

Keywords

  • Biomarkers
  • Cytokines and chemokines
  • Neuroblastoma
  • Relapse

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring'. Together they form a unique fingerprint.

Cite this